AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$40.51
-1.12 (-2.69%)
▼
5d:
-1.89%
30d:
-9.15%
90d:
-11.34%
BUY
MODERATE Confidence
Analysis Updated: Feb 4, 2026 12:00 AM ET
Earnings: Feb 23, 2026
18d
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AORT shows positive signals but monitor for confirmation. Market pricing in 2.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AORT shows positive signals but monitor for confirmation. Market pricing in 2.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.09
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.51
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $40.51, which is considered oversold relative to its 30-day fair value range of $41.64 to $45.03. The stock's valuation (Forward PE: 49.3) is in line with its historical norms (52.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a uptrend. The price is currently testing key support at $39.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AORT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (4th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $51.71 (+24.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AORT is in a uptrend. The price is currently testing key support at $39.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AORT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (4th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $51.71 (+24.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$41.64 -
$45.03
Company Quality Score
54/100
(HOLD)
Options IV Signal
4th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 4th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.2% below Wall St target ($51.71)
Fair Price Analysis
30-Day Fair Range
$41.64 -
$45.03
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$3.23
(8.0%)
Support & Resistance Levels
Support Level
$39.50
Resistance Level
$45.41
Current Trend
Uptrend
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
49.32
Wall Street Target
$51.71
(+24.2%)
Revenue Growth (YoY)
18.4%
Profit Margin
-2.2%
Valuation Discount vs History
-2.0% cheaper
PE vs Historical
49.3 vs 52.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.0%
(market-implied from PE analysis)
1-Year Target
$40.80
(-2%)
2-Year Target
$39.98
(-4%)
3-Year Target
$39.18
(-6%)
3-Yr Target (if PE normalizes)
(PE: 49→52)
$41.62
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 49.3, Growth: 33.1%)
$98.21
(+136%)
Base:
(SPY PE: 22.3, Growth: 33.1%)
$44.40
(+7%)
Bear:
(PE: 19.0, Growth: 33.1%)
$37.74
(-9%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 49.3 to 52.4
Stabilization Target:
$44.23
(+6.2%)
PE Expansion Potential:
+6.2%
Last updated: February 04, 2026 2:28 PM ET
Data refreshes hourly during market hours. Next update: 3:28 PM
Data refreshes hourly during market hours. Next update: 3:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Marshall S Stanton
SELL
18200 shares
2025-08-27
Jean F Holloway
SELL
10000 shares
2025-08-25
James P Mackin
SELL
12500 shares
2025-08-15
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 41 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
